Literature DB >> 24754824

Chronic obstructive pulmonary disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

M Bradley Drummond1, A Sonia Buist, James D Crapo, Robert A Wise, Stephen I Rennard.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a complex set of conditions with multiple risk factors, disease mechanisms, and clinical manifestations. These characteristics make primary prevention of COPD challenging. Semantic issues related to prevalent and incident disease (e.g., the use of specific cut points on a continuous range) should not derail development of primary prevention initiatives. Potential targets for COPD prevention occur along the spectrum of disease development. Understanding risk factors early in life, whether specific to COPD or not, allows for study of interventions to optimize lung function at birth and to prolong the lung function plateau, potentially reducing the development of COPD. It is necessary to identify noninvasive ways to screen for early COPD in those at risk before progression to clinically significant disease. Identification of specific COPD subgroups, such as individuals with chronic bronchitis, those with α1-antitrypsin deficiency, or early radiographic changes with normal spirometry, may offer specific opportunities for primary prevention. A better understanding of why COPD progresses despite smoking cessation is needed. Future research initiatives should also focus on identifying the underlying mechanisms and relevant interventions for nonsmokers with COPD, a currently poorly studied group. Ultimately, preventing the development of COPD will serve to reduce the tremendous burden of this chronic disease worldwide.

Entities:  

Mesh:

Year:  2014        PMID: 24754824      PMCID: PMC5473655          DOI: 10.1513/AnnalsATS.201312-432LD

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  34 in total

1.  Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.

Authors:  Fisun Karadag; Aslihan B Karul; Orhan Cildag; Mustafa Yilmaz; Hatice Ozcan
Journal:  Lung       Date:  2008-09-20       Impact factor: 2.584

Review 2.  Pathogenesis of COPD.

Authors:  John R Spurzem; Stephen I Rennard
Journal:  Semin Respir Crit Care Med       Date:  2005-04       Impact factor: 3.119

3.  An overview of obstructive lung diseases.

Authors:  B Burrows
Journal:  Med Clin North Am       Date:  1981-05       Impact factor: 5.456

Review 4.  Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.

Authors:  Firdaus A A Mohamed Hoesein; Pieter Zanen; Jan-Willem J Lammers
Journal:  Respir Med       Date:  2011-02-05       Impact factor: 3.415

5.  Maternal vitamin A supplementation and lung function in offspring.

Authors:  William Checkley; Keith P West; Robert A Wise; Matthew R Baldwin; Lee Wu; Steven C LeClerq; Parul Christian; Joanne Katz; James M Tielsch; Subarna Khatry; Alfred Sommer
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

6.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

Review 7.  The cytokine network in asthma and chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

8.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.

Authors:  V M Keatings; P D Collins; D M Scott; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

9.  Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study.

Authors:  W M Vollmer; Thorn Gíslason; P Burney; P L Enright; A Gulsvik; A Kocabas; A S Buist
Journal:  Eur Respir J       Date:  2009-05-21       Impact factor: 16.671

10.  Changes in forced expiratory volume in 1 second over time in COPD.

Authors:  Jørgen Vestbo; Lisa D Edwards; Paul D Scanlon; Julie C Yates; Alvar Agusti; Per Bakke; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Courtney Crim; David A Lomas; William MacNee; Bruce E Miller; Edwin K Silverman; Ruth Tal-Singer; Emiel Wouters; Stephen I Rennard
Journal:  N Engl J Med       Date:  2011-09-26       Impact factor: 91.245

View more
  10 in total

1.  The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis.

Authors:  Wayne H Anderson; Raymond D Coakley; Brian Button; Ashley G Henderson; Kirby L Zeman; Neil E Alexis; David B Peden; Eduardo R Lazarowski; C William Davis; Summer Bailey; Fred Fuller; Martha Almond; Bahjat Qaqish; Elena Bordonali; Michael Rubinstein; William D Bennett; Mehmet Kesimer; Richard C Boucher
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

2.  Reply: primary and secondary prevention of chronic obstructive pulmonary disease: where to next?

Authors:  James P Kiley; Gary H Gibbons
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

Review 3.  Executive Summary: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  William W Busse; Serpil C Erzurum; Carol J Blaisdell; Patricia Noel
Journal:  Ann Am Thorac Soc       Date:  2014-04

Review 4.  Early chronic obstructive pulmonary disease: definition, assessment, and prevention.

Authors:  Stephen I Rennard; M Bradley Drummond
Journal:  Lancet       Date:  2015-05-02       Impact factor: 79.321

5.  Intercellular adhesion molecule 1 and progression of percent emphysema: the MESA Lung Study.

Authors:  Carrie P Aaron; Joseph E Schwartz; Suzette J Bielinski; Eric A Hoffman; John H M Austin; Elizabeth C Oelsner; Kathleen M Donohue; Ravi Kalhan; Cecilia Berardi; Joel D Kaufman; David R Jacobs; Russell P Tracy; R Graham Barr
Journal:  Respir Med       Date:  2014-10-22       Impact factor: 3.415

6.  Angiotensin-Converting Inhibitors and Angiotensin II Receptor Blockers and Longitudinal Change in Percent Emphysema on Computed Tomography. The Multi-Ethnic Study of Atherosclerosis Lung Study.

Authors:  Megha A Parikh; Carrie P Aaron; Eric A Hoffman; Joseph E Schwartz; Jaime Madrigano; John H M Austin; Ravi Kalhan; Gina Lovasi; Karol Watson; Karen Hinckley Stukovsky; R Graham Barr
Journal:  Ann Am Thorac Soc       Date:  2017-05

7.  Determining airflow obstruction from tracheal sound analysis: simulated tests and evaluations in patients with acromegaly.

Authors:  Newton A Lima Junior; Nayara V Oliveira; Ana B W Tavares; Agnaldo J Lopes; Pedro L Melo
Journal:  Med Biol Eng Comput       Date:  2022-05-10       Impact factor: 2.602

8.  Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis.

Authors:  William D Bennett; Ashley G Henderson; Agathe Ceppe; Kirby L Zeman; Jihong Wu; Christine Gladman; Fred Fuller; Stephen Gazda; Brian Button; Richard C Boucher; Scott H Donaldson
Journal:  ERJ Open Res       Date:  2020-08-11

9.  Machine learning associated with respiratory oscillometry: a computer-aided diagnosis system for the detection of respiratory abnormalities in systemic sclerosis.

Authors:  Domingos S M Andrade; Luigi Maciel Ribeiro; Agnaldo J Lopes; Jorge L M Amaral; Pedro L Melo
Journal:  Biomed Eng Online       Date:  2021-03-25       Impact factor: 2.819

10.  Protein interaction networks provide insight into fetal origins of chronic obstructive pulmonary disease.

Authors:  Annika Röhl; Seung Han Baek; Priyadarshini Kachroo; Jarrett D Morrow; Kelan Tantisira; Edwin K Silverman; Scott T Weiss; Amitabh Sharma; Kimberly Glass; Dawn L DeMeo
Journal:  Respir Res       Date:  2022-03-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.